Grace Therapeutics, Inc. Annual Return On Equity in % from 2020 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Grace Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2020 to 2023.
  • Grace Therapeutics, Inc. Return On Equity for the quarter ending December 31, 2024 was -23.3 %, a 60.4% increase year-over-year.
  • Grace Therapeutics, Inc. annual Return On Equity for 2023 was -13.9 %, a 68.2% increase from 2022.
  • Grace Therapeutics, Inc. annual Return On Equity for 2022 was -43.9 %, a 13.1% decline from 2021.
  • Grace Therapeutics, Inc. annual Return On Equity for 2021 was -38.8 %, a 94.5% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -13.9 +29.9 +68.2% Apr 1, 2023 Mar 31, 2024
2022 -43.9 -5.08 -13.1% Apr 1, 2022 Mar 31, 2023
2021 -38.8 +663 +94.5% Apr 1, 2021 Mar 31, 2022
2020 -702 Apr 1, 2020 Mar 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.